Retirement Planning Company of New England’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,817
Closed -$23K 227
2023
Q1
$23K Sell
5,817
-52
-0.9% -$205 0.01% 219
2022
Q4
$17.6K Sell
5,869
-3,976
-40% -$11.9K 0.01% 214
2022
Q3
$53K Sell
9,845
-923
-9% -$4.97K 0.04% 206
2022
Q2
$47K Sell
10,768
-8,632
-44% -$37.7K 0.03% 212
2022
Q1
$172K Sell
19,400
-5,155
-21% -$45.7K 0.1% 222
2021
Q4
$216K Buy
+24,555
New +$216K 0.11% 207